← Health Catalyst, Inc. HCAT
Market Price
$1.85
Market Cap
$129.31M
P/E Ratio
N/A
Revenue (FY 2025)
↓-3.5% YoY
$52.48M
3-Yr CAGR: -15.7%
Net Income
N/A
Net Margin: N/A
Free Cash Flow
↓-101.8% YoY
-$237.00K
FCF Yield: -0.18%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: N/A
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (HCAT)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2018: Revenue YoY (+70.2%) is identical to Gross Profit YoY (+70.2%). Verify the underlying Revenue and Gross Profit values for FY 2018 and FY 2017.
- FY 2019: Revenue YoY (+7.2%) is identical to Gross Profit YoY (+7.2%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
- FY 2020: Revenue YoY (+17.2%) is identical to Gross Profit YoY (+17.2%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
- FY 2021: Revenue YoY (+35.4%) is identical to Gross Profit YoY (+35.4%). Verify the underlying Revenue and Gross Profit values for FY 2021 and FY 2020.
- FY 2022: Revenue YoY (+16.6%) is identical to Gross Profit YoY (+16.6%). Verify the underlying Revenue and Gross Profit values for FY 2022 and FY 2021.
- FY 2023: Revenue YoY (-23.1%) is identical to Gross Profit YoY (-23.1%). Verify the underlying Revenue and Gross Profit values for FY 2023 and FY 2022.
- FY 2024: Revenue YoY (-19.2%) is identical to Gross Profit YoY (-19.2%). Verify the underlying Revenue and Gross Profit values for FY 2024 and FY 2023.
- FY 2025: Revenue YoY (-3.5%) is identical to Gross Profit YoY (-3.5%). Verify the underlying Revenue and Gross Profit values for FY 2025 and FY 2024.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $25.9M | — | $25.9M | — | — | — | — | $-36.8M | $-39.3M | — |
| FY 2018 | $44.1M | +70.2% | $44.1M | — | — | — | — | $-40.3M | $-42.6M | -8.3% |
| FY 2019 | $47.3M | +7.2% | $47.3M | — | — | — | — | $-32.2M | $-34.6M | +18.8% |
| FY 2020 | $55.4M | +17.2% | $55.4M | — | — | — | — | $-26.1M | $-33.9M | +1.9% |
| FY 2021 | $75.0M | +35.4% | $75.0M | — | — | — | — | $-23.1M | $-33.6M | +1.0% |
| FY 2022 | $87.5M | +16.6% | $87.5M | — | — | — | — | $-35.3M | $-37.4M | -11.5% |
| FY 2023 | $67.3M | -23.1% | $67.3M | — | — | — | — | $-33.1M | $-34.3M | +8.3% |
| FY 2024 | $54.4M | -19.2% | $54.4M | — | — | — | — | $14.6M | $12.9M | +137.7% |
| FY 2025 | $52.5M | -3.5% | $52.5M | — | — | — | — | $0.7M | $-0.2M | -101.8% |
Valuation
Market Price
$1.85
Market Cap
$129.31M
Enterprise Value
$230.12M
P/E Ratio
N/A
P/B Ratio
0.56
FCF Yield
-0.18%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
24.76%
Operating Margin
N/A
Net Margin
N/A
Return on Equity (ROE)
N/A
Return on Assets (ROA)
N/A
Asset Turnover
0.10x
Revenue 3-Yr CAGR
-15.67%
Financial Health & Liquidity
Current Ratio
1.89
Cash Ratio
0.57
Debt / Equity
0.617
Debt / Assets
0.302
Cash & Equivalents
$50.81M
Total Debt
$151.62M
Book Value / Share
$3.33
Cash Flow Efficiency
Operating Cash Flow
$731.00K
Capital Expenditures (CapEx)
$968.00K
Free Cash Flow
-$237.00K
OCF / Revenue
1.39%
FCF / Revenue
-0.45%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$3.33
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$502.64M
Total Liabilities
$502.64M
Stockholders' Equity
$245.78M
Current Assets
$169.31M
Current Liabilities
$89.57M